SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 544.91 millions against Rs. 529.37 millions during year ago period.The Company to register a -35.99%  fall in the net profit for the quarter ended September 2022.Operating Profit reported a sharp decline to 71.62 millions from 83.94 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 544.91 529.37 2.94 1058.91 1042.06 1.62 2196.63 2448.05 -10.27
Other Income 28.72 27.25 5.39 58.52 40.56 44.28 119.93 71.41 67.95
PBIDT 71.62 83.94 -14.68 136.28 167.23 -18.51 314.56 449.80 -30.07
Interest 6.18 1.20 415.00 11.22 3.09 263.11 13.55 2.71 400.00
PBDT 65.44 82.74 -20.91 125.06 164.49 -23.97 301.25 447.39 -32.67
Depreciation 11.75 9.74 20.64 21.70 19.45 11.57 39.48 40.35 -2.16
PBT 53.69 73.00 -26.45 103.36 145.04 -28.74 261.77 407.04 -35.69
TAX 17.71 16.79 5.48 28.71 34.86 -17.64 63.86 115.32 -44.62
Deferred Tax 3.51 0.12 2825.00 4.21 0.06 6916.67 1.40 2.31 -39.39
PAT 35.98 56.21 -35.99 74.65 110.18 -32.25 197.91 291.72 -32.16
Equity 940.00 829.95 13.26 940.00 829.95 13.26 862.45 789.95 9.18
PBIDTM(%) 13.14 15.86 -17.11 12.87 16.05 -19.80 14.32 18.37 -22.06

Syncom Formulations Share Price

14.70 0.13 (0.89%)
05-Jun-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.40
Dr. Reddys Lab 1273.50
Cipla 1393.10
Zydus Lifesciences 1091.20
Lupin 2275.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×